Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended September 30, 2025
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has submitted a compliance certificate to the stock exchange under the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025. This is a routine quarterly filing that confirms the company is following the required depository participation rules. Such certificates are filed periodically by listed companies as part of their standard regulatory obligations. There are no financial figures, transactions, or business updates involved in this filing.
This is a routine compliance disclosure with no material impact on the stock price or shareholder value. It simply confirms the company has met its quarterly regulatory reporting requirement under SEBI's depository rules.